Efficacy and safety of rifampicin-based triple therapy for non-puerperal mastitis: A single-arm, open-label, prospective clinical trial
Objectives: To assess the efficacy and safety of rifampicin-based triple therapy (rifampicin, isoniazid, and ethambutol) for treating NPM. Methods: This single-center, single-arm, prospective clinical trial was conducted at the Second Hospital of Shandong University (Jinan, China). Patients with pat...
Main Authors: | Fei Zhou, Huanjie Li, Fei Wang, Liyuan Liu, Lixiang Yu, Yujuan Xiang, Chao Zheng, Shuya Huang, Zhigang Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971223008111 |
Similar Items
-
Periductal Mastitis, a Disease with Distinct Clinicopathological Features from Granulomatous Lobular Mastitis
by: Zhou F, et al.
Published: (2024-06-01) -
Management of granulomatous lobular mastitis: an international multidisciplinary consensus (2021 edition)
by: Qian-Qian Yuan, et al.
Published: (2022-04-01) -
Novel insights: crosstalk with non-puerperal mastitis and immunity
by: Yao Zhou, et al.
Published: (2024-08-01) -
Treatment of granulomatous lobular mastitis
by: Ziwei Zhang, et al.
Published: (2023-09-01) -
Retrospective study on oral administration of rifampicin combined with ultrasound-guided puncture in treatment of granulomatous lobular mastitis
by: QIU Yier, WU Yingjie, QIU Qianhui, LU Guowen
Published: (2021-11-01)